Experimental evidence suggests that recommended dosages of some corticoster
oids used clinically as antiinflammatory agents for treating arthropathies
damage articular cartilage, but low dosages may be chondroprotective. The p
urpose of this study was to evaluate how different concentrations of methyl
prednisolone affect chondrocyte function and viability. Articular cartilage
and chondrocytes were obtained from young adult horses, 1.5-3.5 years of a
ge. Corticosteroid-induced changes in collagen expression were studied at t
he transcriptional level by Northern blot analyses and at the translational
level by measuring CM-proline incorporation into CHI-hydroxyproline. Fibro
nectin mRNA splicing patterns were evaluated with ribonuclease protection a
ssays. Cytotoxicity was studied using erythrosin B dye exclusion. Steady-st
ate levels of type II procollagen mRNA decreased without concurrent changes
in type I procollagen expression as the medium methylprednisolone concentr
ations were increased from 1 x 10(1) to 1 X 10(8) pg/ml, dropping below 10%
of control values by I x 101 pg/ml. Cytotoxicity occurred as methylprednis
olone levels were increased further from 1 x 10(8) to 1 x 10(9) pg/ml. Chan
ges in total collagen (protein) synthesis were less pronounced, but also de
monstrated significant suppression between 1 x 10(4) and 1 x 10(8) pg/ml. C
orticosteroid-induced changes in fibronectin isoform levels were evaluated
in articular cartilage samples without in vitro culture. The cartilage-spec
ific (V + C)(-) isoform was suppressed in both normal and inflamed joints b
y a single intraarticular injection (0.1 mg/kg) of methylprednisolone. Comb
ined, these data indicate that methylprednisolone suppresses matrix protein
markers of chondrocytic differentiation. Decreased and altered chondrocyte
expression of matrix proteins likely contributes to the pathogenesis of co
rticosteroid-induced cartilage degeneration. (C) 2001 Orthopaedic Research
Society. Published by Elsevier Science Ltd. All rights reserved.